Breaking News

Mylan Appoints Strategic Ops EVP

By Kristin Brooks | January 9, 2014

Gulfo brings extensive industry experience from Pfizer

Adele Gulfo has been appointed executive vice president, Global Collaboration and Strategic Operations at Mylan, Inc., and will serve as a member of the executive leadership team.
 
Prior to joining the company, Ms. Gulfo served as regional president of Latin America in Pfizer's Emerging Markets Business Unit, where she led a team of more than 4,000 operating across more than 23 countries. Previously, she served as president and general manager of Pfizer's U.S. Primary Care Business Unit, which included the Managed Markets organization for all of Pfizer's Biopharmaceutical Business Units. Earlier in her career at Pfizer, she was instrumental in the launch of Lipitor, and was recognized for developing medical and public education campaigns that helped to establish the significance of lowering cholesterol in preventing and managing heart disease.
 
Additionally, Ms. Gulfo served as vice president of business development, Innovation and Design for Launch at AstraZeneca, and has been awarded five U.S. patents for innovative packaging designed to help patients adhere to their medicines.
 
Mylan chief executive officer Heather Bresch said, "Adele's rich and diverse experience in the pharmaceutical industry will bring significant strategic value and leadership to Mylan in numerous areas. We believe Adele's expertise will support many of our key growth drivers, including our expansion in Latin America, the development and expansion of our global Specialty franchise, and the development of global commercial strategies to maximize key upcoming launches of increasingly complex generic products, such as in the biologics and respiratory areas.”

blog comments powered by Disqus
  • Newsmakers: PCI

    Newsmakers: PCI

    Tim Wright, Editor||June 2, 2015
    PCI execs talk about the recent opening of the company’s new North American clinical facility, as well as other trends in the market

  • How Sterilization of Primary Packaging Influences the Results of E&L Studies

    How Sterilization of Primary Packaging Influences the Results of E&L Studies

    Thorsten Sogding, Daniel Canton, Daniel Haines, Uwe Rothhaar, SCHOTT Pharma Services ||June 2, 2015
    As the demands that are being placed on the quality and stability of medications continue to increase, the interactions that take place between the primary packaging container and filled drug product are becoming increasingly important

  • Moore’s Law for More Health

    Moore’s Law for More Health

    Patrick Jordan , Encore Health Resources||June 2, 2015
    This year marks the semicentennial anniversary of a prediction about exponential growth and productivity